PsyEdu partners with and receives Endorsement from Drug Science for Excellence in Psychedelic Therapy Training

PsyEdu is proud to announce a landmark collaboration with Drug Science, the UK’s leading independent scientific body on drugs and drug policy, to advance high-quality, evidence-based education in the field of psychedelic-assisted therapies.

As part of its mission to uphold the highest standards in psychedelic training, Drug Science conducted an in-depth audit of PsyEdu’s Professional Certificate in Psychedelic Practice. Their review confirmed that PsyEdu’s curriculum is scientifically rigorous, ethically grounded, and aligned with the latest research in psychedelic science.

“Our review confirms that PsyEdu’s educational content reflects the most up-to-date understanding of how psychedelics interact with the body and mind,” said a spokesperson for Drug Science. Their training emphasises safe, supportive, and professionally guided care for individuals in altered states of consciousness—a critical component in the responsible application of psychedelic-assisted therapies.”

Drug Science commended PsyEdu for its commitment to clinical best practice, safety, and therapeutic efficacy, recognising the programme as a valuable contribution to the future of psychedelic healthcare.

“We are delighted to partner with and receive this endorsement from Drug Science,” said Dr Duncan Still (Academic Director) . Managing Director Sam Bloomfield added: “It affirms our belief that psychedelic therapies, when taught with integrity and scientific accuracy, have the power to transform the future of mental health treatment.”

This collaboration marks an important milestone in PsyEdu’s mission to train a compassionate, skilled, and accountable network of practitioners working with altered states of consciousness.

For more information about PsyEdu’s accredited training programmes, visit Here